Pressmeddelanden, rapporter och bolagsmeddelande för Inhalation Sciences

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences signs R&D order worth 257,000 SEK with major generic pharma company
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences receives IRS order worth 1.9 million SEK with US pharma company
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: DDL2022: Inhalation Sciences had several landmark presentations at well-attended event
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences AB (publ) releases Q3 Report 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences AB (publ) publicerar delårsrapport för det tredje kvartalet 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences AB (publ) publicerar delårsrapport för det tredje kvartalet 2022
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences begins planned FDA BAA dissolution research project
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences signs IRS order worth 1.17 million SEK with large generic pharma company
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Sciences signs IRS order worth 1.17 million SEK with large generic pharma company
Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Inhalation Sciences

Press release from Companies: Inhalation Research Services receives revised order with increased payment from US pharma company